Trials / Unknown
UnknownNCT05234762
Efficacy, Safety, and Pharmacokinetics of ES-481 in Adult Patients With Essential Tremors
A Phase 2A, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ES-481 in Adult Patients With Essential Tremors
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 24 (estimated)
- Sponsor
- ES Therapeutics Australia Pty Ltd · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This Pilot Phase 2A study will investigate the safety, tolerability, and pharmacokinetics (PK) of ES-481 in adult patients with essential tremor.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ES-481 | Dose escalation during two Treatment Periods |
| OTHER | Placebo | Placebo dosed at same dosing as ES-481 |
Timeline
- Start date
- 2021-11-21
- Primary completion
- 2023-12-31
- Completion
- 2023-12-31
- First posted
- 2022-02-10
- Last updated
- 2023-03-02
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT05234762. Inclusion in this directory is not an endorsement.